Pharm Derm Exam 1 Flashcards
(117 cards)
ABCDE
For Any Neoplasm
Asymmetry Borders Color Diameter Evolving / elevation
Types of benign tumors
Dermal tumors - acrochordon Cysts Vascular tumors (cherry hemangioma) Tumors of subcutaneous fat (lipoma) Hyperkeratotic reactions to chronic friction (callus/corn)
Premalignant neoplasms
Actinic keratosis appear over the exposed areas of the body as a result of actinic radiation
(solar)
Actinic Keratoses Treatments
Fluorouracil
imiquimod
ingenol mebutate
5 fluorouracil
Efudex (5%)
(Antimetabolite)
Cream or solution
a topical chemotherapy
most common treatment of most common precancer
(actinic keratoses)
Superficial basal cell carcinoma when conventional therapy is impractical
Preg Cat X
Adverse
Pain or burning at application site, pruritis, irritation, hyperpigmentation
5 fluorouracil MOA
Inhibits thymidylate synthetase and incorporates into DNA as an abnormal nucleotide
imiquimod
Aldara (5%) Cream
Actinic keratoses on face or scalp
Immune response modifier that is a Toll like receptor 7 agonist that activates immune cells
ingenol mebutate
Picato
Actinic Keratoses
Cell Death inducer
Actinic Keratoses Treatment options
Lesion directed
Surgery
Cryotherapy
Dermabrasion
Field directed Topical Fluorouracil imiquimod ingenol mebutate
or photodynamic therapy
Bowens disease Treatment
Surgical excision curettage electrodessication Photodynamic therapy Cryotherapy Topical fluorouracil Topical imiquimod
Keratoacanthomas
Conventional surgical excision is the treatment of choice for solitary Keratoacanthomas
Basal cell carcinoma topical treatment
Fluorouracil
imiquimod
Squamous cell carcinoma
If Low recurrence
Treatment
If low risk of recurrence Treatment Surgical excision Mohs surgery Curettage and electrodessication Cryotherapy Photodynamic therapy Radiation therapy (non surgical candidates)
pembrolizumab
Keytruda
Human programmed death receptor 1
PD -1 Blocking antibody
for unresectable metastatic melanoma
Embyro Fetal toxicity
pembrolizumab
MOA
releases the “brake” allowing T cells to act
protein receptor is the “brake”
pembrolizumab (keytruda)
Warnings and precautions
Immune mediated adverse reactions
Immune mediated adverse reactions
Pneumonitis, colitis, hepatitis, hypophysis, nephritis, hyperthyroidism, hypothyroidism
Administer corticosteroids based on severity of reaction
Withhold or discontinue keytruda depending upon severity of reaction
pembrolizumab (keytruda)
Warnings and precautions
Embryofetal toxicity
Keytruda may cause fetal harm
Advise females of reproductive potential to use highly effective birth control during treatment with keytruda and for 4 months after the last dose.
Acne treatments Based on MOA
Inflammation
Oral isotretinoin
Oral tetracycline
Topical retinoids
Azelaic Acid
Acne treatments Based on MOA
C. Acnes proliferation
Benzoyl peroxide
Topical and oral antibiotics
Azelaic acid
Acne treatments Based on MOA
Increased sebum production
Oral isotretinoin
Hormonal therapies
Acne treatments Based on MOA
Follicular Hyperproliferation and abnormal desquamation
Topical retinoids Oral Retinoids Azelaic acid Salicylic acid hormonal therapies
Retinoic acid
most common adverse effects
The most common adverse effects of topical retinoic acid are erythema and dryness that occur in the first few weeks of use
But these can be expected to resolve with continued therapy
Isotretinoin
Accutane
Sever recalcitrant nodular acne unresponsive to conventional therapy (eg. systemic ABX)
Not for children
Preg Cat X
Severe birth defects
Must register patients in Ipledge
Avoid tetracyclines (increased risk of pseudomotor cerebri)
Adverse
Dry skin, eyes, nose, mouth, lips
REMS
To inform patients about the serious risks associated with drug X
To minimize potential drug drug and disease drug interactions
To prevent the risk of fetal exposures to drug X